Association Briefs

Citing the intellectual stimulation of collaboration, the American Society for Cell Biology and the American Society for Biochemistry arid Molecular Biology will hold their annual meetings together for the first time ever next year. After all, notes president Tom Pollard of the ASOB, the two groups share many members and a desire to understand life processes at the molecular level. The 28th annual meeting of ASCB and the 80th annual meeting of ASBMB is scheduled for January 29 through February

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Citing the intellectual stimulation of collaboration, the American Society for Cell Biology and the American Society for Biochemistry arid Molecular Biology will hold their annual meetings together for the first time ever next year. After all, notes president Tom Pollard of the ASOB, the two groups share many members and a desire to understand life processes at the molecular level. The 28th annual meeting of ASCB and the 80th annual meeting of ASBMB is scheduled for January 29 through February 2,1989, in San Francisco, with between 8,000 and 12,000 biological and biomedical researchers expected to attend. ASBMB typically holds a joint meeting with another scientific society once every two or three years; in past years it has broken bread with the American Association of Immunologists and the Biophysical Society.

Since most U.S. science is backed by taxpayers’ dollars, should Congress be involved with evaluating research projects for federal funding? The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies